High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience-Reference-Cited by-同舟云学术

High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience

Published:2020-08-29 Issue:11 Volume:34 Page:840-846
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Wakabayashi Hiroshi^ORCID,Kayano Daiki,Inaki Anri,Araki Raita,Kuroda Rie,Ikawa Yasuhiro,Fujiki Toshihiro,Akatani Norihito,Yamase Takafumi,Watanabe Satoru,Hiromasa Tomo,Kunita Yuji,Mori Hiroshi,Saito Shintaro,Nishimura Ryosei,Wada Taizo,Kinuya Seigo

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12149-020-01514-2.pdf

Reference18 articles.

1. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298–303. https://doi.org/10.1200/JCO.2008.16.6876.

2. Cotterill SJ, Pearson AD, Pritchard J, Foot AB, Roald B, Kohler JA, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992. Eur J Cancer. 2000;36:901–8.

3. London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol. 2011;29:3286–92. https://doi.org/10.1200/JCO.2010.34.3392.

4. Lee JW, Lee S, Cho HW, Ma Y, Yoo KH, Sung KW, et al. Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study. J Hematol Oncol. 2017;10:108. https://doi.org/10.1186/s13045-017-0477-0.

5. Suh JK, Koh KN, Min SY, Kim YS, Kim H, Im HJ, et al. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with (131) I-MIBG therapy for high-risk neuroblastoma. Pediatr Transplant. 2020;24:e13658. https://doi.org/10.1111/petr.13658.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Verfahren und Techniken bei Phäochromozytomen und Paragangliomen;Nuklearmedizin bei endokrinen Erkrankungen;2024

2. Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma;Journal of Nuclear Medicine;2023-02-02

3. Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience;Frontiers in Oncology;2022-12-23

4. Procedures and Techniques in Pheochromocytomas and Paragangliomas;Nuclear Medicine in Endocrine Disorders;2022

5. Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation;European Journal of Nuclear Medicine and Molecular Imaging;2021-11-27